ACH-3102

ACH-3102 is an investigational medication used to treat hepatitis C.

ACH-3102 Overview

Reviewed: February 9, 2015
Updated: 

ACH-3102 is an investigational medication used to treat hepatitis C.

ACH-3102 when used in combination with Sovaldi eradicated signs of the virus after six weeks of therapy.

ACH-3102 belongs to a group of drugs called second-generation NS5A inhibitors. These work by inhibiting a specific target that plays a role on viral replication and assembly.

ACH-3102 is being developed and studied by Achillion Pharmaceuticals.

ACH-3102 is an investigational medication. Its safety and efficacy have not been established.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Manufacturer

Back to Top

ACH-3102 Drug Class

Back to Top

ACH-3102 is part of the drug class: